AUTHOR=Richards Oliver , Jenkins Cerys , Griffiths Helena , Paczkowska Edyta , Dunstan Peter R. , Jones Sharon , Morgan Margery , Thomas Tanya , Bowden Jayne , Nakimuli Annettee , Nair Manju , Thornton Catherine A. TITLE=Vibrational Spectroscopy: A Valuable Screening and Diagnostic Tool for Obstetric Disorders? JOURNAL=Frontiers in Global Women's Health VOLUME=1 YEAR=2021 URL=https://www.frontiersin.org/journals/global-womens-health/articles/10.3389/fgwh.2020.610582 DOI=10.3389/fgwh.2020.610582 ISSN=2673-5059 ABSTRACT=

Preeclampsia (PE) is a common obstetric disorder typically affecting 2–8% of all pregnancies and can lead to several adverse obstetric outcomes for both mother and fetus with the greatest burden of severe outcomes in low middle-income countries (LMICs), therefore, screening for PE is vital. Globally, screening is based on maternal characteristics and medical history which are nonspecific for the disorder. In 2004, the World Health Organization acknowledged that no clinically useful test was able to predict the onset of PE, which prompted a universal search for alternative means of screening. Over the past decade or so, emphasis has been placed on the use of maternal characteristics in conjunction with biomarkers of disease combined into predictive algorithms, however these are yet to transition into the clinic and are cost prohibitive in LMICs. As a result, the screening paradigm for PE remains unchanged. It is evident that novel approaches are needed. Vibrational spectroscopy, specifically Raman spectroscopy and Fourier-transform infrared spectroscopy (FTIR), could provide better alternatives suited for implementation in low resource settings as no specialized reagents are required for conventional approaches and there is a drive to portable platforms usable in both urban and rual community settings. These techniques are based on light scattering and absorption, respectively, allowing detailed molecular analysis of samples to produce a unique molecular fingerprint of diseased states. The specificity of vibrational spectroscopy might well make it suited for application in other obstetric disorders such as gestational diabetes mellitus and obstetric cholestasis. In this review, we summarize current approaches sought as alternatives to current screening methodologies and introduce how vibrational spectroscopy could offer superior screening and diagnostic paradigms in obstetric care. Additionally, we propose a real benefit of such tools in LMICs where limited resources battle the higher prevalence of obstetric disorders.